China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
Abone Ol
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
Severe dust storm sweeps 9 Arab states, worsening Gaza’s
-
Putin signs decree renaming Volgograd airport to histori
-
Denmark, Norway condemn Israeli attacks on humanitarian
-
US judge finds Apple in contempt for violating antitrust
-
South Korea’s presidential front-runner Lee to face retr
-
UK says Israel's blockade of aid delivery into Gaza is '
-
Japan's premier urges US to abolish tariffs as 2 sides s
-
Trump says he should be given time to fix ‘Biden’s econo
-
Voters head to ballot box for local elections in England
-
Over 1.4M Syrians have gone home since fall of Assad, sa
